<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A discussion is provided of the cytologic abnormalities in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), which remain central to the diagnosis and classification of these conditions </plain></SENT>
<SENT sid="1" pm="."><plain>Accurate identification of the blast cells is essential since the proportion of these cells is of considerable prognostic significance </plain></SENT>
<SENT sid="2" pm="."><plain>A description is given of the FAB classification scheme, which is both simple and reproducible </plain></SENT>
<SENT sid="3" pm="."><plain>Prognostic scoring systems based on bone marrow blast proportion, cytopenias, and karyotypic abnormalities are also discussed </plain></SENT>
</text></document>